Cargando…
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid...
Autores principales: | Bitterman, Lauren, Solhjoo, Mahdis, Shah, Vivek, Kwon, Sue Min, Torralba, Karina, Kazbour, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102817/ https://www.ncbi.nlm.nih.gov/pubmed/37052044 http://dx.doi.org/10.1177/23247096231165736 |
Ejemplares similares
-
Catastrophic Antiphospholipid Syndrome
por: El-Shereef, Rawhya R., et al.
Publicado: (2016) -
The Catastrophic Antiphospholipid Syndrome
por: Rodríguez-Pintó, Ignasi, et al.
Publicado: (2014) -
COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
por: El Hasbani, Georges, et al.
Publicado: (2020) -
Catastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic Complications
por: Vieregge, Gerardo B., et al.
Publicado: (2013) -
Lupus-Negative Libman-Sacks Endocarditis Complicated by Catastrophic Antiphospholipid Syndrome
por: Murtaza, Ghulam, et al.
Publicado: (2017)